The Cigna Group reported a strong start to the year, with first-quarter 2025 revenues rising 14% to $65.5 billion.

The results were the company's first since its March capital markets day, when it said it would grow top-line production and increase shareholder returns over the next five years. Cigna Group swung to ...

Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

Cigna Group on Friday reported a $1.3 billion profit for the first quarter of 2025, a sharp turnaround from a year-earlier ...

The telemedicine firm acquired Union Square-based UpLift for $30 million, offering an additional $15 million if the company ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Q1 2025 Management View The CEO, David Cordani, highlighted that total revenue reached $65.5 billion for the quarter, with ...

The SG&A expense ratio and adjusted SG&A expense ratio were 6.4% and 5.8%, respectively, for the first quarter of 2025, ...

Cigna (CI) unveils ENGUIDE, a specialized GLP-1 pharmacy to be launched next month as demand for obesity drugs like Wegovy ...

Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...

Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid ...

The results make UnitedHealth Group’s earnings blowup last month look less and less like a sector-wide problem.